845 related articles for article (PubMed ID: 11838345)
1. [Arrhythmia risk stratification in patients with heart failure. Foreword].
Opasich C; Santini M
Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345
[TBL] [Abstract][Full Text] [Related]
2. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
Ansalone G; Ricci R; Cacciatore G; Santini M
Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
[TBL] [Abstract][Full Text] [Related]
3. [Risk stratification and prevention of sudden death in patients with heart failure].
Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A
Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066
[TBL] [Abstract][Full Text] [Related]
4. [Arrhythmia risk stratification in patients with heart failure: prognostic evaluation of arrhythmia risk].
Lombardi F
Ital Heart J Suppl; 2001 Dec; 2(12):1284-90. PubMed ID: 11838349
[TBL] [Abstract][Full Text] [Related]
5. [Arrhythmia risk stratification based on etiological and anatomo-structural factors].
Disertori M; Dallafior D; Marini M
Ital Heart J Suppl; 2001 Dec; 2(12):1265-9. PubMed ID: 11838346
[TBL] [Abstract][Full Text] [Related]
6. [Variables of arrhythmia risk in relation to pacemaker and implantable defibrillator].
Solano A; Oddone D; Croci F; Donateo P; Puggioni E; Brignole M
Ital Heart J Suppl; 2001 Dec; 2(12):1303-7. PubMed ID: 11838352
[TBL] [Abstract][Full Text] [Related]
7. [The stratification and prevention of the arrhythmia risk in nonischemic dilated cardiomyopathy].
Ansalone G; Giannantoni P; Santini M
G Ital Cardiol; 1998 Nov; 28(11):1288-302. PubMed ID: 9866807
[TBL] [Abstract][Full Text] [Related]
8. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic therapy in heart failure.
Eckardt L; Haverkamp W; Breithardt G
Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
[TBL] [Abstract][Full Text] [Related]
11. [Cardiac resynchronization therapy-always with ICD?].
Stellbrink C
Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
[TBL] [Abstract][Full Text] [Related]
12. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
[TBL] [Abstract][Full Text] [Related]
13. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G
Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
[TBL] [Abstract][Full Text] [Related]
14. Biventricular pacing in patients with ICD: how many patients are possible candidates?
Werling C; Weisse U; Siemon G; Kiessling AH; Rameken M; Schwacke H; Saggau W; Senges J; Seidl K
Thorac Cardiovasc Surg; 2002 Apr; 50(2):67-70. PubMed ID: 11981703
[TBL] [Abstract][Full Text] [Related]
15. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
[TBL] [Abstract][Full Text] [Related]
16. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
18. Biventricular pacing and defibrillator use in chronic heart failure.
Cesario DA; Turner JW; Dec GW
Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
[TBL] [Abstract][Full Text] [Related]
19. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
Das M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
[TBL] [Abstract][Full Text] [Related]
20. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
